Literature DB >> 2504616

An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats.

S R Winn1, L Wahlberg, P A Tresco, P Aebischer.   

Abstract

The effect of sustained intrastriatal release of dopamine (DA) from polymer matrices on apomorphine-induced turning behavior in a 6-hydroxydopamine (6-OHDA) unilaterally lesioned rat model was analyzed. A biocompatible semipermeable tube was placed in a denervated striatum as a receptacle for DA-releasing polymer rods. In vitro kinetics showed sustained release of DA from a polymeric rod for 15 days. Implantation of a DA-releasing rod within the striatal receptacle significantly decreased apomorphine-induced rotational behaviour in lesioned animals. Upon removal of the DA-releasing system from the receptacle, rotational behaviour increased within 2 weeks and approached preimplant control values 4 weeks later. Acute microdialysis revealed that DA appeared in the extracellular space within 20 min after the implantation of a DA-releasing rod into a denervated striatum. Significant DA amounts were still measurable 7 days postimplantation, indicating sustained DA release from the polymer rod. Dopamine released from a polymer matrix through a semipermeable receptacle alleviates experimental parkinsonism in rats, suggesting that controlled intrastriatal release of DA from a polymer matrix may provide an alternative method for the treatment of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504616     DOI: 10.1016/0014-4886(89)90126-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

Review 1.  Behavioural consequences of neural transplantation.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 2.  Distribution of drugs following controlled delivery to the brain interstitium.

Authors:  M Mak; L Fung; J F Strasser; W M Saltzman
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

3.  Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum.

Authors:  C Nicholson
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

4.  Polymeric controlled-release amsacrine chemotherapy in an experimental glioma model.

Authors:  L U Wahlberg; P M Almqvist; M J Glantz; J Boëthius
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  The efficacy of alginate encapsulated CHO-K1 single chain-TRAIL producer cells in the treatment of brain tumors.

Authors:  Jos M A Kuijlen; Bart J de Haan; Wijnand Helfrich; Jan-Freark de Boer; Douwe Samplonius; Jan Jakob A Mooij; Paul de Vos
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

6.  Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat.

Authors:  R Barker; S B Dunnett
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

7.  "Hydrocephalus-parkinsonism complex": progressive hydrocephalus as a factor affecting extrapyramidal tract disorder-an experimental study.

Authors:  Shizuo Oi; Dong Seok Kim; Mitsuru Hidaka
Journal:  Childs Nerv Syst       Date:  2003-11-05       Impact factor: 1.475

8.  Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not by noradrenaline-releasing polymer matrices.

Authors:  M Kokaia; P Aebischer; E Elmér; J Bengzon; P Kalén; Z Kokaia; O Lindvall
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

9.  Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats.

Authors:  A McRae; E A Ling; S Hjorth; A Dahlström; D Mason; T Tice
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.